Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hawkins

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The American Journal on Addictions|February 4, 2022
Are x-waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x-waiver trainingsAdam J Gordon, Marie Kenny, Matthew Dungan, et al.
Journal of Medicinal Chemistry|May 24, 2016
Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl TransferaseMichael J Genin, Isabel C Gonzalez Valcarcel, William G Holloway, et al.
JAMA Network Open|March 4, 2025
Veterans at High Risk for Post-COVID-19 Suicide Attempts or Other Self-Directed ViolenceDavid P Bui, Meike Niederhausen, Alex W Hickok, et al.
Molecular Endocrinology (Baltimore, Md.)|April 16, 2005
A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemiaAnne Reifel-Miller, Keith Otto, Eric Hawkins, et al.
Addiction Science & Clinical Practice|May 19, 2017
Patient-centered primary care for adults at high risk for AUDs: the Choosing Healthier Drinking Options In primary CarE (CHOICE) trialKatharine A Bradley, Evette Joy Ludman, Laura J Chavez, et al.
Health Services Research|June 6, 2025
Veteran Mental Health Emergency Care Utilization Following SARS-CoV-2 InfectionJason I Chen, Meike Niederhausen, David P Bui, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
The development of potent and selective bisarylmaleimide GSK3 inhibitorsThomas A Engler, Sushant Malhotra, Timothy P Burkholder, et al.
Journal of Medicinal Chemistry|July 23, 2004
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3Thomas A Engler, James R Henry, Sushant Malhotra, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituentsJosé A Martín, Dawn A Brooks, Lourdes Prieto, et al.
MMWR. Morbidity and Mortality Weekly Report|September 16, 2021
Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status - 13 U.S. Jurisdictions, April 4-July 17, 2021Heather M Scobie, Amelia G Johnson, Amitabh B Suthar, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The American Journal on Addictions|February 4, 2022
Are x-waiver trainings enough? Facilitators and barriers to buprenorphine prescribing after x-waiver trainingsAdam J Gordon, Marie Kenny, Matthew Dungan, et al.
Journal of Medicinal Chemistry|May 24, 2016
Imidazopyridine and Pyrazolopiperidine Derivatives as Novel Inhibitors of Serine Palmitoyl TransferaseMichael J Genin, Isabel C Gonzalez Valcarcel, William G Holloway, et al.
JAMA Network Open|March 4, 2025
Veterans at High Risk for Post-COVID-19 Suicide Attempts or Other Self-Directed ViolenceDavid P Bui, Meike Niederhausen, Alex W Hickok, et al.
Molecular Endocrinology (Baltimore, Md.)|April 16, 2005
A peroxisome proliferator-activated receptor alpha/gamma dual agonist with a unique in vitro profile and potent glucose and lipid effects in rodent models of type 2 diabetes and dyslipidemiaAnne Reifel-Miller, Keith Otto, Eric Hawkins, et al.
Addiction Science & Clinical Practice|May 19, 2017
Patient-centered primary care for adults at high risk for AUDs: the Choosing Healthier Drinking Options In primary CarE (CHOICE) trialKatharine A Bradley, Evette Joy Ludman, Laura J Chavez, et al.
Health Services Research|June 6, 2025
Veteran Mental Health Emergency Care Utilization Following SARS-CoV-2 InfectionJason I Chen, Meike Niederhausen, David P Bui, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2005
The development of potent and selective bisarylmaleimide GSK3 inhibitorsThomas A Engler, Sushant Malhotra, Timothy P Burkholder, et al.
Journal of Medicinal Chemistry|July 23, 2004
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3Thomas A Engler, James R Henry, Sushant Malhotra, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
2-Alkoxydihydrocinnamates as PPAR agonists. Activity modulation by the incorporation of phenoxy substituentsJosé A Martín, Dawn A Brooks, Lourdes Prieto, et al.
MMWR. Morbidity and Mortality Weekly Report|September 16, 2021
Monitoring Incidence of COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Status - 13 U.S. Jurisdictions, April 4-July 17, 2021Heather M Scobie, Amelia G Johnson, Amitabh B Suthar, et al.
Pageof 3